Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peicheng Li

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Small Science|April 11, 2025
Interface Engineering in Organic Electronics: Energy-Level Alignment and Charge TransportPeicheng Li, Zheng-Hong Lu
Advanced Materials (Deerfield Beach, Fla.)|April 25, 2017
Mapping Energy Levels for Organic HeterojunctionsYiying Li, Peicheng Li, Zheng-Hong Lu
Molecular Medicine Reports|July 18, 2017
Glucagon-like peptide-1 analogue liraglutide ameliorates atherogenesis via inhibiting advanced glycation end product-induced receptor for advanced glycosylation end product expression in apolipoprotein-E deficient micePeicheng Li, Zhaosheng Tang, Lin Wang, et al.
BMC Endocrine Disorders|September 27, 2017
The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intoleranceXinfeng Yan, Peicheng Li, Zhaosheng Tang, et al.
Cytokine|July 2, 2025
Exploring the role of immune cell traits and circulating inflammatory cytokines in the development of diabetic neuropathyNuojin Guo, Qijun Li, Hua Wang, et al.
Scientific Reports|September 17, 2016
Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatmentLin Wang, Peicheng Li, Zhaosheng Tang, et al.
Annals of Translational Medicine|September 27, 2019
Effects of GLP-1 receptor analogue liraglutide and DPP-4 inhibitor vildagliptin on the bone metabolism in ApoE<sup>-/-</sup> miceLizhi Zhang, Peicheng Li, Zhaosheng Tang, et al.
Journal of Diabetes Research|September 16, 2016
Microflora Disturbance during Progression of Glucose Intolerance and Effect of Sitagliptin: An Animal StudyXinfeng Yan, Bo Feng, Peicheng Li, et al.
Molecular Medicine Reports|October 5, 2022
[Retracted] IL‑33 attenuates cardiac remodeling following myocardial infarction via inhibition of the p38 MAPK and NF‑κB pathwaysHonglei Yin, Peicheng Li, Fudong Hu, et al.
Molecular Medicine Reports|March 15, 2014
IL-33 attenuates cardiac remodeling following myocardial infarction via inhibition of the p38 MAPK and NF-κB pathwaysHonglei Yin, Peicheng Li, Fudong Hu, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Small Science|April 11, 2025
Interface Engineering in Organic Electronics: Energy-Level Alignment and Charge TransportPeicheng Li, Zheng-Hong Lu
Advanced Materials (Deerfield Beach, Fla.)|April 25, 2017
Mapping Energy Levels for Organic HeterojunctionsYiying Li, Peicheng Li, Zheng-Hong Lu
Molecular Medicine Reports|July 18, 2017
Glucagon-like peptide-1 analogue liraglutide ameliorates atherogenesis via inhibiting advanced glycation end product-induced receptor for advanced glycosylation end product expression in apolipoprotein-E deficient micePeicheng Li, Zhaosheng Tang, Lin Wang, et al.
BMC Endocrine Disorders|September 27, 2017
The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intoleranceXinfeng Yan, Peicheng Li, Zhaosheng Tang, et al.
Cytokine|July 2, 2025
Exploring the role of immune cell traits and circulating inflammatory cytokines in the development of diabetic neuropathyNuojin Guo, Qijun Li, Hua Wang, et al.
Scientific Reports|September 17, 2016
Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatmentLin Wang, Peicheng Li, Zhaosheng Tang, et al.
Annals of Translational Medicine|September 27, 2019
Effects of GLP-1 receptor analogue liraglutide and DPP-4 inhibitor vildagliptin on the bone metabolism in ApoE<sup>-/-</sup> miceLizhi Zhang, Peicheng Li, Zhaosheng Tang, et al.
Journal of Diabetes Research|September 16, 2016
Microflora Disturbance during Progression of Glucose Intolerance and Effect of Sitagliptin: An Animal StudyXinfeng Yan, Bo Feng, Peicheng Li, et al.
Molecular Medicine Reports|October 5, 2022
[Retracted] IL‑33 attenuates cardiac remodeling following myocardial infarction via inhibition of the p38 MAPK and NF‑κB pathwaysHonglei Yin, Peicheng Li, Fudong Hu, et al.
Molecular Medicine Reports|March 15, 2014
IL-33 attenuates cardiac remodeling following myocardial infarction via inhibition of the p38 MAPK and NF-κB pathwaysHonglei Yin, Peicheng Li, Fudong Hu, et al.
Pageof 5